Bharat Immunologicals (India) Valuation Overview

BIBCL -- India Stock  

INR 11.26  0.37  3.18%

Bharat Immunologicals shows prevailing Real Value of 10.038 per share. The current price of the firm is 11.26. At this time the firm appears to be over valued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Profit Margin of (11.79)% and Return On Equity of (10.18)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Horizon     30 Days    Login   to change
Bharat Immunologicals Biologicals Corp Ltd is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about  1.10  of Price to Sales per Price to Book.

Current Market Valuation

Bharat Immunologicals Valuation Boundaries

Over Valued
December 14, 2018
11.26
Market Value
10.04
Real Value
Target Odds
  
20.54
Upside
Bharat Immunologicals is relatively risky asset. Calculation of real value of Bharat Immunologicals is based on 2 months time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
Search macroaxis.com